Efficacy of Baloxavir Against Influenza in Hospitalized Patients: The INFLUENT Study (INpatients inFLUENza Treatment)

Clinical trial NCT06653569 · RECRUITING

Trial details

NCT number: NCT06653569
Sponsor: Dre Pauline Vetter
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Influenza Disease; Flu

Start date: 2024-12-13
Primary completion: 2027-04-01
Enrollment: 484

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.